Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 237.88 |
| Open | 237.20 |
| Bid | 234.67 x 100 |
| Ask | 234.97 x 100 |
| Day's range | 233.42 - 240.31 |
| 52-week range | 141.98 - 263.73 |
| Volume | |
| Avg. volume | 1,028,688 |
| Market cap | 29.705B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.64 |
| Earnings date | 01 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 261.15 |
ZacksAlnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Alnylam (ALNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Simply Wall St.Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) is possibly approaching a major achievement in its business, so we would...
Business WireAlnylam to Webcast Conference Call Discussing Second Quarter 2024 Financial Results
CAMBRIDGE, Mass., July 18, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2024 on Thursday, August 1, 2024, before the U.S. financial markets open.
© 2024 Yahoo. All rights reserved.